[1]
Martins, P.; Jesus, J.; Santos, S.; Raposo, L.R.; Rodrigues, C.R.; Baptista, P.V.; Fernandes, A.R. Heterocyclic anticancer compounds: Recent advances and the paradigm shift towards the use of nanomedicine’s tool box. Molecules, 2015, 20, 16852-16891.
[2]
Yi-Fong Chen, Y.; Lin, Y.; Morris-Natschke, S.L.; Wei, C.; Shen, T.; Lin, H.; Hsu, M.; Chou, L.; Zhao, Y.; Kuo, K.; Lee, K.; Huang, L. Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activity. Br. J. Pharmacol., 2015, 172, 1195-1221.
[3]
Vitaku, E.; Smith, D.T.; Njardarson, J.T. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem., 2014, 57, 10257-10274.
[4]
aGomtsyan, A. Heterocycles in drugs and drug discovery. Chem. Heterocycl. Compd., 2012, 48, 7-10.
bAlvárez-Builla, J.; Barluenga, J. Heterocyclic compounds: An introduction. Mod. Heterocycl. Chem., 2011, 1, 1-9.
[5]
Jorda, R.; Havlicek, L.; McNae, I.W.; Walkinshaw, M.D.; Voller, J.; Sturc, A. Pyrazolo[4,3-d]pyrimidine bioisostere of roscovitine: evaluation of a novel selective inhibitor of cyclin-dependent kinases with antiproliferative activity. J Med Chem., 2011, 54, 2980-2993. (b) Banh, T.N.; Kode, N.R.; Phadtare, S. Aryl and acyclic unsaturated derivatives of thioguanine and 6-mercaptopurine: Synthesis and cytotoxic activity. Lett. Drug Des. Discov., 2011, 8, 709-716.
[6]
Sharma, V.L.; Paul, K. Synthesis and evaluation of novel N, N-disubstituted benzimidazolium bromides salts as antitumor agents. Eur. J. Med. Chem., 2015, 93, 414-422.
[7]
Vikrant, V.; Sharma, P.; Dhiman, S.; Noolvi, M.N.; Patel, H.M.; Bhardwaj, V. Small hybrid heteroaromatics: Resourceful biological tools in cancer research. RSC Advances, 2017, 7, 28313-28349.
[8]
aJadeja, Y.; Kapadiya, K.; Shah, A.; Khunt, R. Importance of HMBC and NOE 2D NMR techniques for the confirmation of regioselectivity. Magn. Reson. Chem., 2016, 54, 75-80.
bKapadiya, K.; Jadeja, Y.; Khunt, R. Synthesis of purine based triazoles by copper (I)-catalyzed huisgen azide-alkyne cycloaddition reaction. J. Heterocycl. Chem., 2018, 55(1), 199-208.
[9]
Kapadiya, K.; Pandya, M.; Rathod, C.; Dhaduk, B. Anti-cancer investigation of newly derived alicyclic ring and morpholine supported hybrid molecules by industrially viable route. J. Scient. Indust. Res., 2018, 77, 402-409. (b) Kapadiya, K.M.; Kavadia, K.M.; Manvar, P.A.; Khunt, R.C. Synthesis of nitrogen and oxygen based pyrazole derivatives and its antitubercular and antimicrobial activity. Antiinfect. Agents, 2015, 13(2), 129-138.
[10]
Kapadiya, K. Synthesis and pharmacological studies of some new
heterocyclic entities. Ph.D. Dissertation, Saurashtra University, Gujarat,
India. 2017.
[11]
Boyed, M.; Paull, K. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev. Res., 1995, 34, 91-109.
[12]
Ciszewski, L.; Waykole, L.; Prashad, M.; Repić, O. A Practical synthesis of 2-arylamino-6-alkylaminopurines from 2,6-dichloropurine. Org. Process Res. Dev., 2006, 10(4), 799-802.
[13]
Al-Suwaidan, I.A.; Abdel-Aziz, N.I.; El-Azab, A.S.; El-Sayed, M.A.; Alanazi, A.M.; El-Ashmawy, M.B.; Abdel-Aziz, A.M. Antitumor evaluation and molecular docking study of substituted 2-benzylidenebutane-1,3-dione, 2-hydrazonobutane-1,3-dione and trifluoromethyl-1H-pyrazole analogues. J. Enzyme Inhib. Med. Chem., 2015, 30(4), 679-687.